News 2025

03.02.2025
New RNA-based biomarker TB27 enables rapid monitoring of therapy response in tuberculosis
Borstel, 03.02.2025 – A team of researchers led by Dr. Maja Reimann at the Research Center Borstel, Leibniz Lung Center, has developed an RNA-based biomarker that can monitor treatment response in tuberculosis (TB) without bacterial culture.

30.01.2025
Molecular Bacterial Load Assay (MBLA): New method can rapidly and accurately predict the effectiveness of tuberculosis therapy
Emerging drug-resistant strains are posing significant challenges to the global fight against tuberculosis (TB) and it is a critical task to detect treatment failure as early as possible. Researchers from the Marius Nasta Institute (MNI) and the Research Center Borstel, Leibniz Lung Center (FZB) have now evaluated a new test for the early detection of changes in the bacterial load of Mycobacterium tuberculosis, which provides an indication of treatment success within hours. The results of the study have now been published in the Journal of Infection.